Featured
Advertisement
Trending - Altmetric
-
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
-
Update on the development of Group A Streptococcus vaccines
-
Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
-
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza